What are the Challenges in Using Nanotechnology for Anticancer Drugs?
Despite its potential, the use of nanotechnology in anticancer drugs faces several challenges:
Toxicity and Biocompatibility: Ensuring that nanomaterials are non-toxic and biocompatible is critical for their safe use in humans. Regulatory Hurdles: The regulatory approval process for nanomedicines is complex and requires extensive testing to ensure safety and efficacy. Manufacturing and Scalability: Producing nanoparticles consistently and at scale poses significant technical and economic challenges.
